{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:43:43Z","timestamp":1786999423628,"version":"build-2736575974"},"reference-count":52,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0899823X20003566_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the effectiveness of chlorhexidine (CHG) dressings to prevent catheter-related bloodstream infections (CRBSIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X20003566_as2\">\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X20003566_as3\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We searched PubMed, CINAHL, EMBASE, and\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:uri>\n                      for studies (randomized controlled and quasi-experimental trials) with the following criteria: patients with short- or long-term catheters; CHG dressings were used in the intervention group and nonantimicrobial dressings in the control group; CRBSI was an outcome. Random-effects models were used to obtain pooled risk ratios (pRRs). Heterogeneity was evaluated using the\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      test and the Cochran Q statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X20003566_as4\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 20 studies (18 randomized controlled trials; 15,590 catheters) without evidence of publication bias and mainly performed in intensive care units (ICUs) were included. CHG dressings significantly reduced CRBSIs (pRR, 0.71; 95% CI, 0.58\u20130.87), independent of the CHG dressing type used. Benefits were limited to adults with short-term central venous catheters (CVCs), including onco-hematological patients. For long-term CVCs, CHG dressings decreased exit-site\/tunnel infections (pRR, 0.37; 95% CI, 0.22\u20130.64). Contact dermatitis was associated with CHG dressing use (pRR, 5.16; 95% CI, 2.09\u201312.70); especially in neonates and pediatric populations in whom severe reactions occurred. Also, 2 studies evaluated and did not find CHG-acquired resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X20003566_as5\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CHG dressings prevent CRBSIs in adults with short-term CVCs, including patients with an onco-hematological disease. CHG dressings might reduce exit-site and tunnel infections in long-term CVCs. In neonates and pediatric populations, proof of CHG dressing effectiveness is lacking and there is an increased risk of serious adverse events. Future studies should investigate CHG effectiveness in non-ICU settings and monitor for CHG resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ice.2020.356","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T05:38:43Z","timestamp":1600234723000},"page":"1388-1395","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":37,"title":["Effectiveness of chlorhexidine dressings to prevent catheter-related bloodstream infections. Does one size fit all? A systematic literature review and meta-analysis"],"prefix":"10.1017","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-2218","authenticated-orcid":false,"given":"Mireia","family":"Puig-Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre R.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli N.","family":"Perencevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin L.","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"S0899823X20003566_ref7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajic.2015.08.022","article-title":"Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters","volume":"44","author":"Karpanen","year":"2016","journal-title":"Am J Infect Control"},{"key":"S0899823X20003566_ref26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2016561","article-title":"Chlorhexidine-impregnated dressings and prevention of catheter-associated bloodstream infections in a pediatric intensive care unit","volume":"36","author":"Duzkaya","year":"2016","journal-title":"Crit Care Nurse"},{"key":"S0899823X20003566_ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir257"},{"key":"S0899823X20003566_ref43","first-page":"27","article-title":"Impact on catheter-related bloodstream infections with the use of the BIOPATCH dressing","volume":"7","author":"Banton","year":"2002","journal-title":"JVAD"},{"key":"S0899823X20003566_ref35","doi-asserted-by":"crossref","DOI":"10.1111\/ijn.12776","article-title":"Chlorhexidine gluconate transparent dressing does not decrease central-line\u2013associated bloodstream infection in critically ill patients: a randomized controlled trial","author":"Yu","year":"2019","journal-title":"Int J Nurs Pract"},{"key":"S0899823X20003566_ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s15010-014-0689-y","article-title":"Attributable mortality of central-line\u2013associated bloodstream infection: systematic review and meta-analysis","volume":"43","author":"Ziegler","year":"2015","journal-title":"Infection"},{"key":"S0899823X20003566_ref29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1590\/0104-1169.3443.2478","article-title":"Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial","volume":"22","author":"Pedrolo","year":"2014","journal-title":"Rev Lat Am Enfermagem"},{"key":"S0899823X20003566_ref2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1473-3099(15)00409-0","article-title":"Effectiveness of insertion and maintenance bundles to prevent central-line\u2013associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis","volume":"16","author":"Ista","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"S0899823X20003566_ref18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-136-11-200206040-00007","article-title":"Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis","volume":"136","author":"Chaiyakunapruk","year":"2002","journal-title":"Ann Intern Med"},{"key":"S0899823X20003566_ref42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4037\/ccn2012956","article-title":"Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients","volume":"32","author":"Pfaff","year":"2012","journal-title":"Crit Care Nurse"},{"key":"S0899823X20003566_ref45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/592411","article-title":"Getting to zero: is it safe?","volume":"30","author":"Edmond","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0899823X20003566_ref25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.iccn.2017.11.002","article-title":"Effect of an acrylic terpolymer barrier film beneath transparent catheter dressings on skin integrity, risk of dressing disruption, catheter colonisation and infection","volume":"46","author":"Pivkina","year":"2018","journal-title":"Intensive Crit Care Nurs"},{"key":"S0899823X20003566_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"S0899823X20003566_ref19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1542\/peds.107.6.1431","article-title":"A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates","volume":"107","author":"Garland","year":"2001","journal-title":"Pediatrics"},{"key":"S0899823X20003566_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.03.006"},{"key":"S0899823X20003566_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000172934.98865.14"},{"key":"S0899823X20003566_ref15","doi-asserted-by":"crossref","unstructured":"15. Higgins, JPT , Thomas, J , Chandler, J , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions, version 6.0. Cochrane Training website. www.training.cochrane.org\/handbook. Updated July 2019. Accessed July 24, 2019.","DOI":"10.1002\/9781119536604"},{"key":"S0899823X20003566_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq108"},{"key":"S0899823X20003566_ref46","first-page":"e1","article-title":"Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients","volume":"1130","author":"Wall","year":"2014","journal-title":"J Crit Care"},{"key":"S0899823X20003566_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"S0899823X20003566_ref40","unstructured":"40. Talbot, TR , Stone, EC , Irwin, K , Overholt, AD , Dasti, M , Kallen, A , for the Healthcare Infection Control Practices Advisory Committeee. 2017 Updated recommendations on the use of chlorhexidine-impregnated dressings for prevention of intravascular-related infections. Center for Disease Control and Prevention website. https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/guidelines\/c-i-dressings-H.pdf. Published 2017. Accessed November 11, 2019."},{"key":"S0899823X20003566_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2013.01.310"},{"key":"S0899823X20003566_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.aucc.2018.11.001"},{"key":"S0899823X20003566_ref8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010367.pub2","article-title":"Dressings and securement devices for central venous catheters (CVC)","author":"Ullman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"S0899823X20003566_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2017.02.008"},{"key":"S0899823X20003566_ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306801"},{"key":"S0899823X20003566_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05617-x"},{"key":"S0899823X20003566_ref13","unstructured":"13. Higgins, JPT , Green, S (editors). Measures of relative effect: the risk ratio and odds ratio. In: Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. Cochrane Training website. https:\/\/handbook-5-1.cochrane.org\/chapter_9\/9_2_2_2_measures_of_relative_effect_the_risk_ratio_and_odds.htm. Updated March 2011. Accessed August 7, 2019."},{"key":"S0899823X20003566_ref20","unstructured":"20. Maki, DG , Mermel, LA , Kluger, D , Narans, L , Knasinski, V , Parenteau, S , Covington, P . The efficacy of a chlorhexidine-impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection: A prospective, randomized, controlled, multicenter study. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto; 2000."},{"key":"S0899823X20003566_ref33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00277-008-0568-7","article-title":"Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial","volume":"88","author":"Ruschulte","year":"2009","journal-title":"Ann Hematol"},{"key":"S0899823X20003566_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S1036-7314(98)70426-6"},{"key":"S0899823X20003566_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000319"},{"key":"S0899823X20003566_ref51","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajic.2010.11.008","article-title":"Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central-line\u2013associated infections in the United States","volume":"39","author":"Ye","year":"2011","journal-title":"Am J Infect Control"},{"key":"S0899823X20003566_ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr191"},{"key":"S0899823X20003566_ref21","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31822f0d4b"},{"key":"S0899823X20003566_ref36","first-page":"57","article-title":"Yal\u00e7Inba\u015f Y, San D, Ulukol A. Comparison of catheter related infection rates in pediatric cardiovascular surgery patients with use of transparent cover and transparent cover saturated with chlorhexidin gluconate in central catheter care","volume":"15","author":"Arpa","year":"2013","journal-title":"Turkish J Res Dev Nurs"},{"key":"S0899823X20003566_ref27","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/annonc\/mdw275","article-title":"A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients","volume":"27","author":"Biehl","year":"2016","journal-title":"Ann Oncol"},{"key":"S0899823X20003566_ref14","unstructured":"14. Higgins, JPT , Green, S (editors). How to include multiple groups from one study. In: Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. Cochrane Training website. https:\/\/handbook-5-1.cochrane.org\/chapter_16\/16_5_4_how_to_include_multiple_groups_from_one_study.htm. Updated March 2011. Accessed December 7, 2019"},{"key":"S0899823X20003566_ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2016.08.018"},{"key":"S0899823X20003566_ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4029-9"},{"key":"S0899823X20003566_ref22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jama.2009.376","article-title":"Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial","volume":"301","author":"Timsit","year":"2009","journal-title":"JAMA"},{"key":"S0899823X20003566_ref50","doi-asserted-by":"crossref","first-page":"e0130439","DOI":"10.1371\/journal.pone.0130439","article-title":"Cost-effectiveness analysis of a transparent antimicrobial dressing for managing central venous and arterial catheters in intensive care units","volume":"10","author":"Maunoury","year":"2015","journal-title":"PLoS One"},{"key":"S0899823X20003566_ref16","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"S0899823X20003566_ref47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15698\/mic2019.07.683","article-title":"Adaptive bacterial response to low level chlorhexidine exposure and its implications for hand hygiene","volume":"6","author":"Kampf","year":"2019","journal-title":"Microb Cell"},{"key":"S0899823X20003566_ref31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhin.2005.01.023","article-title":"Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial","volume":"61","author":"Chambers","year":"2005","journal-title":"J Hosp Infect"},{"key":"S0899823X20003566_ref52","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.10269"},{"key":"S0899823X20003566_ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2207-x"},{"key":"S0899823X20003566_ref23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1038OC"},{"key":"S0899823X20003566_ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061115"},{"key":"S0899823X20003566_ref4","unstructured":"4. Annual Epidemiological Report for 2017. Healthcare-associated infections acquired in intensive care units. European Centre for Disease Prevention and Control website. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-HAI.pdf. Published 2019. Accessed October 31, 2019."},{"key":"S0899823X20003566_ref37","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.342.14810"},{"key":"S0899823X20003566_ref12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X20003566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:51:09Z","timestamp":1607064669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X20003566\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0899823X20003566"],"URL":"https:\/\/doi.org\/10.1017\/ice.2020.356","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"\u00a9 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}